PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  

Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice

2024-11-12
(Press-News.org) RENTON, Wash. [Nov. 12, 2024] – New real-world data from Providence, Illumina (NASDAQ: ILMN), and Microsoft Research reveals that Comprehensive Genomic Profiling (CGP), when done early in a cancer patient’s diagnosis, leads to better personalized treatment and patient outcomes. The findings come out of the first two years of a five-year, real-world study, which was published today in the Journal of Clinical Oncology - Oncology Practice (JCO-OP). 

Through a novel approach, the study employed pathologist-driven CGP testing making test results available 12 days prior to the patient’s initial medical oncologist visit. The study found that the availability of test results at the initial visit influenced the early clinical decision-making process and led to over half of the patients receiving biomarker-driven targeted therapy or immunotherapy, which in turn significantly improved overall survival of 25 months for patients treated with targeted therapy compared to patients treated with chemotherapy alone.  

By observing test actionability rates, therapy choice and outcomes across 3,216 advanced cancer patients across several cancer types, the study found:

CGP test can identify actionable mutations based on either guideline-based treatment or clinical-trial matching for 67% of tumors, compared to only 33% of tumors with small-panel test 52% of CGP-tested patients received a matched targeted therapy or immunotherapy as opposed to 32% of patients who received conventional systemic chemotherapy alone. Patients who received a targeted therapy had significantly better overall survival as opposed to patients who received only chemotherapy (25 months vs. 17 months, p<0.001) The publication of this paper comes on the heels of another study from this team of researchers, which found a similar clinical impact for advanced non-small-cell lung cancer (NSCLC) patients tested with CGP.  This recently published study presented comparative analysis between patients with advanced NSLCL tested with CGP and small panel and found that in comparison to small panel-tested patients, CGP patients had a higher rate of actionable mutations (77% vs. 63%, p<0.001), patients with actionable mutations received matched precision therapies at a higher rate (64% vs. 50%, p<0.001) and improvement in overall survival (median: 16 months vs. 7 months, p<0.0001).

“Both of these novel studies, as well as the impact of the findings, underscores the importance of CGP being folded into standard of care diagnostic practices,” said Carlo Bifulco, M.D., chief medical officer of Providence Genomics and a co-author of the study. “By getting CGP test results in the hands of pathologists and oncologists at the onset of a cancer diagnosis, we witnessed CGP-tested patients received biomarker-matched therapy at a higher rate, which often led to better outcomes.” 

CGP, which assesses hundreds of cancer biomarkers across various tumor types in a single test, can guide patients toward targeted treatments or immunotherapies that may not have been identified through more limited genomic testing approaches. This type of testing is increasingly being adopted due to its broad scope and faster turnaround times compared to sequential single-gene tests or small panels. However, barriers to access remain, including insurance coverage and other logistical challenges. 

For payers, these results build evidence that a CGP approach prior to treatment initiation improves survival compared to conventional small-panel testing. “For evidence-driven coverage decisions, improved patient outcomes—particularly survival—are the key determinant, said John Fox, senior director of Market Access at Illumina.  “These real-world results across multiple solid tumor types should empower plans to cover CGP as a first-line test.”

“Patients who received a CGP test in this study did so free of charge,” Providence bioinformatics scientist and lead author of the study Alexa Dowdell, MS, said. “By removing the barrier that most often prevents patients from receiving this test, we were able to observe a sizeable cohort and witness the effectiveness of tumor molecular profiling and the precision therapies that often followed.”   

Using a natural language processing-based approach developed by Microsoft Research collaborators, Providence clinical researchers were able to quickly and efficiently parse through large sets of publications, clinical trials, and electronic health records. These AI capabilities assisted Providence researchers with genomics interpretation and clinical trial matching in the molecular tumor boards.

“These results further illustrate the paradigm shift in clinical practice in oncology,” said Swaroop Aradhya, head of Medical and Clinical Affairs at Illumina. “Patients are seeing better outcomes from precision treatments based on a tumor’s molecular profile compared to conventional approaches used to treat cancer.

###

About Providence
Providence is a national, not-for-profit Catholic health system comprising a diverse family of organizations and driven by a belief that health is a human right. With 51 hospitals, more than 1,100 physician clinics, senior services, supportive housing, and many other health and educational services, the health system and its partners employ more than 129,000 caregivers serving communities across seven states – Alaska, California, Montana, New Mexico, Oregon, Texas, and Washington, with system offices in Renton, Wash., and Irvine, Calif. Learn about our vision of health for a better world at Providence.org.

 

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on X, Facebook, LinkedIn, Instagram, TikTok, and YouTube.

END



ELSE PRESS RELEASES FROM THIS DATE:

Animated movie characters with strabismus are more likely to be villains, study finds

2024-11-12
Strabismus, a misalignment of the eyes that occurs especially in children, has no bearing on intelligence or personality, but animated movies tend to use the condition to signify a villainous, dopey, or clumsy character, according to a new study from researchers at the University of Colorado School of Medicine. “When animators are figuring out what a character is going to look like, they have to decide on every little detail of that character's appearance, and so it's not by chance that an animated character happens to have strabismus,” says Michael ...

How retailers change ordering strategy when a supplier starts its own direct channel

2024-11-12
Researchers from Erasmus University and KU Leuven published a new Journal of Marketing study that examines how retailers respond when suppliers establish direct channels to reach end-consumers and how suppliers can take steps to avoid a backlash. The study, forthcoming in the Journal of Marketing, is titled “How Retailers Change Ordering Strategies When Suppliers Go Direct” and is authored by Michiel Van Crombrugge, Els Breugelmans, Femke Gryseels, and Kathleen Cleeren. Recently, Sony began selling PlayStation products through its PlayStation Direct online store in the UK, ...

Young coral use metabolic tricks to resist bleaching

Young coral use metabolic tricks to resist bleaching
2024-11-12
Coral larvae reduce their metabolism and increase nitrogen uptake to resist bleaching in high temperatures, according to a study published November 12th in the open-access journal PLOS Biology by Ariana S. Huffmyer of the University of Washington, US, and colleagues. High ocean temperatures cause coral bleaching, which results from the disruption of the relationship between corals and their symbiotic algae, an increasing concern as global temperatures rise. However, relatively little research has examined the effects of high temperatures ...

Protecting tax whistleblowers pays off

2024-11-12
AUSTIN, Texas — The federal tax gap — money people and companies owe Uncle Sam but fail to pay on time — has climbed to historic highs: $696 billion in 2022, according to the IRS. It’s money that, if recouped, could fund infrastructure or education or pay down government debt. One way to collect that money is through lawsuits prompted by corporate whistleblowers — often present or former employees who know a company’s finances and expose its transgressions. Federal law includes ...

Bioluminescent proteins made from scratch enable non-invasive, multi-functional biological imaging

Bioluminescent proteins made from scratch enable non-invasive, multi-functional biological imaging
2024-11-12
Bioluminescence is the natural chemical process of light creation in some living creatures that makes fireflies flicker and some jellyfish glow. Scientists have long been interested in borrowing the secrets of these animals' light-producing genes to create similar effects in vertebrates, for a variety of biomedical applications. UC Santa Cruz Assistant Professor of Biomolecular Engineering Andy Yeh is designing completely artificial proteins that produce bioluminescence to serve as a non-invasive method for bioimaging, diagnostics, drug discovery, and more. A new paper published in the flagship journal Chem reports on a new series of bioluminescent ...

New study links air pollution with higher rates of head and neck cancer

2024-11-12
DETROIT — A recent study published in the journal Scientific Reports correlates higher levels of pollutant particulate matter to higher occurrences of head and neck aerodigestive cancer. The article, "Air Pollution Exposure and Head and Neck Cancer Incidence," is the work of a multi-institutional collaboration with researchers from Wayne State University, Johns Hopkins University and Mass General Brigham. The study was led by John Cramer, Ph.D., associate professor of otolaryngology, and John Peleman, M.D., medical resident in the Department of Otolaryngology, in the Wayne State University School of Medicine. They collaborated with Mass General Brigham, an integrated ...

LSU researchers excavate earliest ancient Maya salt works

LSU researchers excavate earliest ancient Maya salt works
2024-11-12
The team was led by LSU Alumni Professor Heather McKillop, who first discovered wooden buildings preserved there below the sea floor, along with associated artifacts, and the only ancient Maya wooden canoe paddle in 2004. Her key collaborator, Assistant Professor Elizabeth Sills at the University of Texas at Tyler, began working with McKillop as a master’s student and then as a doctoral student at LSU. Since their initial discovery of wood below the sea floor in Belize, the team has uncovered an extensive pattern of sites that include “salt kitchens” for boiling ...

Building a diverse wildland fire workforce to meet future challenges

2024-11-12
Every year around this time, California’s wildland firefighters hold their breath as hot, dry winds threaten to spread flames across the state. As such conflagrations grow in size and severity throughout the Western U.S., the strain on fire managers has intensified. A new report from Stanford University’s Climate and Energy Policy Program provides a blueprint for fostering a more inclusive, diverse and well-supported workforce to meet the increasing need for fire mitigation and management. “The wellbeing of the wildland fire workforce has ...

MBARI researchers discover remarkable new swimming sea slug in the deep sea

MBARI researchers discover remarkable new swimming sea slug in the deep sea
2024-11-12
MBARI researchers have discovered a remarkable new species of sea slug that lives in the deep sea. Bathydevius caudactylus swims through the ocean’s midnight zone with a large gelatinous hood and paddle-like tail, and lights up with brilliant bioluminescence. The team published a description of the animal, nicknamed the “mystery mollusc,” in the journal Deep-Sea Research Part I. “Thanks to MBARI’s advanced underwater technology, we were able to prepare the most comprehensive description of a deep-sea animal ever made. We’ve ...

Decentralized social media ‘increases citizen empowerment’, says Oxford study

2024-11-12
Researchers from the Oxford Martin Programme on Ethical Web and Data Architectures (University of Oxford) have reported findings from a paper exploring the motivations and challenges in running decentralised social media such as Mastodon, concluding such platforms offer potential for increased citizen empowerment in this digital domain. In their study, presented at the 27th ACM SIGCHI Conference on Computer-Supported Cooperative Work & Social Computing (CSCW) today, the researchers interviewed 16 administrators of Mastodon servers (otherwise known as instances), including those supporting marginalised and stigmatised communities. Their ...

LAST 30 PRESS RELEASES:

Community partners key to success of vaccine clinic focused on neurodevelopmental conditions

Low-carbon collaborative dual-layer optimization for energy station considering joint electricity and heat demand response

McMaster University researchers uncover potential treatment for rare genetic disorders

The return of protectionism: The impact of the Sino-US trade war

UTokyo and NARO develop new vertical seed distribution trait for soybean breeding

Research into UK’s use of plastic packaging finds households ‘wishcycle’ rather than recycle – risking vast contamination

Vaccine shows promise against aggressive breast cancer

Adverse events affect over 1 in 3 surgery patients, US study finds

Outsourcing adult social care has contributed to England’s care crisis, argue experts

The Lancet: Over 800 million adults living with diabetes, more than half not receiving treatment, global study suggests

New therapeutic approach for severe COVID-19: faster recovery and reduction in mortality

Plugged wells and reduced injection lower induced earthquake rates in Oklahoma

Yin selected as a 2024 American Society of Agronomy Fellow

Long Covid could cost the economy billions every year

Bluetooth technology unlocks urban animal secrets

This nifty AI tool helps neurosurgeons find sneaky cancer cells

Treatment advances, predictive biomarkers stand to improve bladder cancer care

NYC's ride-hailing fee failed to ease Manhattan traffic, new NYU Tandon study reveals

Meteorite contains evidence of liquid water on Mars 742 million years ago

Self-reported screening helped reduce distressing symptoms for pediatric patients with cancer

Which risk factors are linked to having a severe stroke?

Opening borders for workers: Abe’s profound influence on Japan’s immigration regime

How skills from hospitality and tourism can propel careers beyond the industry

Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby

New model system for the development of potential active substances used in condensate modifying drugs

How to reduce social media stress by leaning in instead of logging off

Pioneering research shows sea life will struggle to survive future global warming

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery 

Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023

Repurposing semaglutide and liraglutide for alcohol use disorder

[Press-News.org] Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  
Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice